ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,531 | -40.5% | 19,700 | -8.4% | 0.00% | – |
| Q1 2023 | $7,619 | -94.4% | 21,500 | -94.9% | 0.00% | -100.0% |
| Q4 2022 | $136,029 | -75.1% | 423,900 | -43.5% | 0.00% | -80.0% |
| Q3 2022 | $547,000 | -36.5% | 749,700 | -21.7% | 0.01% | -37.5% |
| Q2 2022 | $862,000 | -42.8% | 957,400 | -5.3% | 0.01% | -42.9% |
| Q1 2022 | $1,506,000 | -32.7% | 1,010,700 | -2.0% | 0.01% | -30.0% |
| Q4 2021 | $2,238,000 | -50.5% | 1,031,500 | -18.8% | 0.02% | -57.4% |
| Q3 2021 | $4,524,000 | -43.3% | 1,270,967 | -8.5% | 0.05% | -44.7% |
| Q2 2021 | $7,973,000 | -5.3% | 1,389,006 | -14.4% | 0.08% | -17.5% |
| Q1 2021 | $8,423,000 | +2670.7% | 1,622,824 | +1173.8% | 0.10% | +2475.0% |
| Q4 2020 | $304,000 | -35.9% | 127,400 | -33.1% | 0.00% | -76.5% |
| Q2 2019 | $474,000 | -86.2% | 190,500 | -78.1% | 0.02% | -85.7% |
| Q1 2019 | $3,431,000 | – | 868,793 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 719,282 | $2,359,245 | 0.35% |
| Defender Capital, LLC. | 114,520 | $357,302 | 0.13% |